A Study To Test PF-04449913 (Glasdegib) With Intensive or Non-Intensive Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
A Phase 1b/2 Study to Evaluate the Safety and Efficacy of PF-04449913, an Oral Hedgehog Inhibitor, in Combination With Intensive Chemotherapy, Low Dose Ara-C or Decitabine in Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Category & Conditions: Cancer
Medicine: DAURISMO TABLETS(GLASDEGIB)
ClinicalTrials.gov Identifier (NCT): NCT01546038
Protocol ID: B1371003
PrintDownloadOpen Plain Language Summary Result: Click here